Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase-Reference-Cited by-同舟云学术

Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase

Published:2007-03-09 Issue:3 Volume:321 Page:848-855
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Amrein Lilian,Loignon Martin,Goulet Anne-Christine,Dunn Michael,Jean-Claude Bertrand,Aloyz Raquel,Panasci Lawrence

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference36 articles.

1. Imatinib sensitizes CLL lymphocytes to chlorambucil

2. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia

3. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs that modulate resistance to antitumor agents;Medicinal Chemistry of Anticancer Drugs;2023

2. Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer;Anti-Cancer Agents in Medicinal Chemistry;2022-02

3. Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment;Experimental Hematology & Oncology;2021-11-03

4. DNA repair pathways as guardians of the genome: Therapeutic potential and possible prognostic role in hematologic neoplasms;DNA Repair;2020-12

5. Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment;BMC Research Notes;2019-09-24